Keywords
Deinogest
Levonorgestrel-releasing intrauterine system
Clinical efficacy
Submitted : 2022-08-31
Accepted : 2022-09-15
Published : 2022-09-30
Abstract
Objective: To compare the clinical efficacy and adverse reactions of dienogest and levonorgestrel-releasing intrauterine system in the treatment of adenomyosis. Methods: A total of 60 cases of adenomyosis admitted to Dezhou Women and Children’s Hospital from January 2020 to October 2021 were selected and randomly divided into two groups (Group A and Group B), which were initiated on dienogest and levonorgestrel-releasing intrauterine system, respectively. The therapeutic effects and adverse reactions of the two groups were analyzed. Results: After 6 months of treatment, the uterine volume in the LNG-IUS group reduced slightly compared with that before treatment, with no statistical significance (p > 0.05), while that in the DNG group increased slightly compared with that before treatment, with no statistical significance (p > 0.05). After 6 months of treatment, the hemoglobin of patients in both groups increased compared with that before treatment; there was no significant difference in the DNG group (p > 0.05), but there was significant difference in the LNG-IUS group (p < 0.01). After 6 months of treatment, the VAS scores of the two groups were significantly lower than those before treatment (p < 0.01); the serum CA125 level in both groups decreased significantly compared with that before treatment (p < 0.01). Conclusion: Mirena (levonorgestrel-releasing intrauterine system) has better therapeutic effect on adenomyosis and fewer adverse reactions than deinogest.
References
Endometriosis Professional Committee of Gynecologist and Obstetrician Branch of Chinese Medical Doctor Association, 2020, Diagnosis and Treatment of Adenomyosis in China. Chinese Journal of Obstetrics and Gynecology, 55(06): 376–383.
Xu K, Lu C, Yang Y, et al., 2021, Progress in the Treatment of Adenomyosis. Journal of Mudanjiang Medical College, 42(03): 132–134.
Wang J, He W, Zhou X, et al., 2022, Comparison of Clinical Effects of Dinoprogen and Leuproline in the Adjuvant Treatment of Ovarian Endometriosis Cyst. Chinese Journal of Obstetrics and Gynecology, 23(03): 275–277.
Zheng Y, Yi X, Xu C, 2020, Research Progress on the Application of Dinogestrin in the Treatment of Endometriosis. Chinese Journal of Reproduction and Contraception, 40(10): 828–831.
Tao G, 2021, Research Progress of Clinical Application of Dinogestrin. China Prescription Drugs, 19(09): 28–29.
Yang X, Liu Z, Li H, et al., 2021, Meta Analysis of GnRH-a Combined with Levonorgestrel Intrauterine Sustained Release System in the Treatment of Adenomyosis. China Medical Herald, 18(02): 73–77.
Ren L, He S, Chen H, 2022, Clinical Effect of Manyuele on Adenomyosis. China Maternal and Child Health Care, 37(02): 278–281.
Matsushima T, Akira S, Fukami T, et al., 2018, Efficacy of Hormonal Therapies for Decreasing Uterine Volume in Patients with Adenomyosis. Gynecol Minim Invasive Ther, 7(3): 119–123.
Wang Q, Fu X, Zhu J, 2022, Efficacy Analysis and Safety Evaluation of Dinogestrin in the Treatment of Adenomyosis. Chinese Journal of Practical Gynecology and Obstetrics, 38(01): 105–107.
Hirata T, Izumi G, Takamura M, et al., 2014, Efficacy of Dienogest in the Treatment of Symptomatic Adenomyosis: A Pilot Study. Gynecol Endocrinol, 30(10): 726–729.
Guo X, Zhu H, 2021, Effect of Leuproline Combined with LNG-IUS in the Treatment of Adenomyosis. Clinical Practice of Integrated Traditional Chinese and Western Medicine, 21(17): 38–40.
Zeng W, 2020, Clinical Efficacy of Levonorgestrel Intrauterine Device in the Treatment of Adenomyosis. Electronic Journal of Practical Gynecological Endocrinology, 7(17): 41–42.
Takeuchi A, Koga K, Miyashita M, et al., 2016, Dienogest Reduces Proliferation, NGF Expression and Nerve Fiber Density in Human Adenomyosis. Eur J Obstet Gynecol Reprod Biol, 207: 157–161.
Osuga Y, Watanabe M, Hagino A, 2017, Long-Term Use of Dienogest in the Treatment of Painful Symptoms in Adenomyosis. The Journal of Obstetrics and Gynaecology Research, 43(9): 1441–1448.
Qu J, Mai X, Hu D, et al., 2021, A Clinical Comparative Study on the Treatment of Adenomyosis with Intrauterine Contraceptive System of Dinoprogen and Levonorgestrel. Sino Foreign Medical, 40(29): 117–120.